Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

Recurrent major depressive disorder (rMDD) is a relapsing-remitting disease with high morbidity and a 5-year risk of recurrence of up to 80%. This was a prospective pilot study to examine the potential diagnostic and prognostic value of targeted plasma metabolomics in the care of patients with rMDD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transl Psychiatry
Hauptverfasser: Mocking, Roel J. T., Naviaux, Jane C., Li, Kefeng, Wang, Lin, Monk, Jonathan M., Bright, A. Taylor, Figueroa, Caroline A., Schene, Aart H., Ruhé, Henricus G., Assies, Johanna, Naviaux, Robert K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7801396/
https://ncbi.nlm.nih.gov/pubmed/33431800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-01182-w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge